This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Randolph, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Randolph, C.
PEDIATRICS Vol. 114 No. 2 August 2004, pp. 544-545

SUPPLEMENT ARTICLE

EFFECTS OF BUDESONIDE INHALATION SUSPENSION, COMPARED WITH CROMOLYN SODIUM NEBULIZER SOLUTION, ON HEALTH STATUS AND CAREGIVER QUALITY OF LIFE IN CHILDHOOD ASTHMA

Christopher Randolph, MD

Waterbury, CT

The first 20% of the full text of this article appears below.

Murphy KR, Fitzpatrick S, Cruz-Rivera M, et al. Pediatrics. 2003;112:e212–e219


   Purpose of the Study.
 
To compare the effects of 2 nebulized antiinflammatory asthma medications on asthma control and caregiver quality of life.


   Study Population.
 
Children 2 to 6 years of age, with mild/moderate persistent asthma, were studied.


   Methods.
 
This was a 52-week randomized trial in which the children received either budesonide inhalation suspension (0.5 mg once or twice daily) (N = 168) or cromolyn sodium nebulizer solution (20 mg 4 times daily) (N = 167) initially for 8 weeks, after which the dosage was adjusted at the discretion of the investigator. The Pediatric Asthma Caregiver’s Quality of Life Questionnaire, Compliance/Caregiver Satisfaction . . . [Full Text of this Article]